title: Re: Letter to the editor by Dr. Steven M. Pollack and author's response from Drs. Thomas J. Pallasch and Jorgen Slots. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association.
authors.forename: A S
authors.initials: AS
authors.lastname: Dajani
authors.forename: K A
authors.initials: KA
authors.lastname: Taubert
mesh_terms: D000572:American Heart Association; D004697:Endocarditis, Bacterial / Q000517:prevention & control*; D004917:Erythromycin / Q000008:administration & dosage / Q000031:analogs & derivatives; D015643:Erythromycin Ethylsuccinate / Q000008:administration & dosage; D006801:Humans; D010517:Periodontics; D014481:United States
chemical_list: D015643:Erythromycin Ethylsuccinate; D004917:Erythromycin; C011462:erythromycin stearate